BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6488409)

  • 1. Effects of beta- and gamma-cyclodextrins on release of betamethasone from ointment bases.
    Otagiri M; Fujinaga T; Sakai A; Uekama K
    Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2401-5. PubMed ID: 6488409
    [No Abstract]   [Full Text] [Related]  

  • 2. Different mode of prednisolone within alpha-, beta-, and gamma-cyclodextrins in aqueous solution and in solid state.
    Uekama K; Sakai A; Arimori K; Otagiri M; Saitô H
    Pharm Acta Helv; 1985; 60(4):117-21. PubMed ID: 4011623
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of beta- and dimethyl beta-cyclodextrins on release and percutaneous absorption behaviors of prednisolone from some ointment bases].
    Uekama K; Masaki K; Arimori K; Irie T; Hirayama F
    Yakugaku Zasshi; 1987 Jun; 107(6):449-56. PubMed ID: 3681663
    [No Abstract]   [Full Text] [Related]  

  • 4. Increasing the solubility characteristics of griseofulvin with gamma-cyclodextrin.
    Kata M; Tüske B
    Pharmazie; 1988 Jan; 43(1):52-3. PubMed ID: 3375309
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement in the percutaneous absorption of beclomethasone dipropionate by gamma-cyclodextrin complexation.
    Uekama K; Otagiri M; Sakai A; Irie T; Matsuo N; Matsuoka Y
    J Pharm Pharmacol; 1985 Aug; 37(8):532-5. PubMed ID: 2864411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of oral bioavailability of spironolactone by beta- and gamma-cyclodextrin complexations.
    Seo H; Tsuruoka M; Hashimoto T; Fujinaga T; Otagiri M; Uekama K
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):286-91. PubMed ID: 6850944
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement in percutaneous absorption of prednisolone by beta- and gamma-cyclodextrin complexations.
    Uekama K; Arimori K; Sakai A; Masaki K; Irie T; Otagiri M
    Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2910-3. PubMed ID: 3677241
    [No Abstract]   [Full Text] [Related]  

  • 8. [Spray embedding of vinpocetin with beta-cyclodextrin].
    Kata M; György E
    Pharmazie; 1982 May; 37(5):386-7. PubMed ID: 7111372
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular cavity filling and tabletting with beta-cyclodextrin].
    Hüttenrauch R; Fricke S
    Pharmazie; 1985 May; 40(5):361-2. PubMed ID: 4034643
    [No Abstract]   [Full Text] [Related]  

  • 10. Alkylation of cyclomalto-oligosaccharides (cyclodextrins) with dialkyl sulfate-barium hydroxide: heterogeneity of products and the marked effect of the size of the macrocycle.
    Irie T; Fukunaga K; Pitha J; Uekama K; Fales HM; Sokolowski EA
    Carbohydr Res; 1989 Oct; 192():167-72. PubMed ID: 2611775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of sarin and soman by cyclodextrins in vitro.
    Désiré B; Saint-André S
    Experientia; 1987 Apr; 43(4):395-7. PubMed ID: 3569488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between crystallinity of beta-cyclodextrin and tablet characteristics.
    Nakai Y; Yamamoto K; Terada K; Kajiyama A
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5110-2. PubMed ID: 3830437
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppositories containing cyclodextrin complexes. Part 2: Dissolution and absorption studies.
    Szente L; Apostol I; Gerlóczy A; Szejtli J
    Pharmazie; 1985 Jun; 40(6):406-7. PubMed ID: 4034649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of solubility of furosemide with beta-cyclodextrin.
    Kata M; Antal A
    Pharmazie; 1984 Dec; 39(12):856-7. PubMed ID: 6531396
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes.
    Ohtani Y; Irie T; Uekama K; Fukunaga K; Pitha J
    Eur J Biochem; 1989 Dec; 186(1-2):17-22. PubMed ID: 2598927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives.
    Yoshida A; Yamamoto M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4075-80. PubMed ID: 3245985
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol.
    Loftsson T; Bodor N
    Acta Pharm Nord; 1989; 1(4):185-94. PubMed ID: 2590460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrin complexation of barbiturates in aqueous solution.
    Han SM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2825-7. PubMed ID: 6524658
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of beta- and gamma-cyclodextrins on the pharmacokinetic behavior of prednisolone after intravenous and intramuscular administrations to rabbits.
    Arimori K; Uekama K
    J Pharmacobiodyn; 1987 Aug; 10(8):390-5. PubMed ID: 3694434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
    Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
    Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.